Urovant Sciences acquires licensing for hMaxi-K gene therapy to treat overactive bladder from Ion Channel

Urovant Sciences has secured global licensing rights from Ion Channel Innovations for the development and commercialization of a promising gene therapy, hMaxi-K. This therapy is ... Read More